Company Snapshot: Myomo, Inc.
Myomo, Inc. is a medical robotics company that offers expanded mobility for those suffering from neurological disorders and upper-limb paralysis. Based on patented technology developed at MIT, Harvard Medical School and by the Company, Myomo develops and markets the MyoPro® product line of lightweight, non-invasive, powered arm braces (orthoses) to restore function in the paralyzed or weakened arms and hands of individuals that have suffered a stroke, spinal cord or nerve injury such as brachial plexus injury, or other neuro-muscular disability such as amyotrophic lateral sclerosis (ALS) or multiple sclerosis (MS). It is the only device that, sensing a patient’s own neurological signals through non-invasive sensors on the arm, can restore their ability to use their arms and hands so that they can return to work, live independently and reduce their cost of care. Published clinical research shows a clinically significant instantaneous reduction in upper extremity impairment through use of MyoPro. MyoPro is referred for patients at leading rehabilitation facilities, including Mayo Clinic, Cleveland Clinic, Massachusetts General Hospital, Kennedy Krieger Institute, Loma Linda Medical Center and twenty VA hospitals, among others. It is fitted and delivered through a nationwide network of orthotics and prosthetics practices, and over 600 have been used by patients. Myomo is headquartered in Cambridge, Massachusetts, with sales and clinical professionals across the U.S.
- May 14 2020 Myomo Reports 2020 First Quarter Financial Results
- May 12 2020 Myomo to Report First Quarter Financial Results on May 14, 2020
- Apr 8 2020 Myomo Reports Accelerating Growth in MyoPro Pipeline and Record Backlog in the First Quarter of 2020, Provides Update on the Business Impact of COVID-19
- Mar 18 2020 Myomo, Inc., to Present at the New York City based Investor Summit on March 25th-26th